Bio

David, the practice group leader of the firm’s Mergers and Acquisitions group, guides clients from across the country and economic sectors through their most complicated M&A transactions, consistently providing practical business solutions to complex legal and financial issues.  Through precision, experience, and dedication to his clients’ success, David structures transactions in highly technical and regulated industries that maximize value and minimize key risks.  In doing so, clients ranging from technology and life sciences companies to private equity funds, venture capital funds, family offices, and their portfolio companies praise his combination of efficient and cost-effective services of the highest caliber with his plain-English, common-sense guidance.   

Prior to joining the firm in 2008, David practiced with a multinational law firm.

David received his B.A., summa cum laude, from Duke University and his J.D., cum laude, from New York University School of Law. Before transferring to NYU, he attended Harvard Law School where he was an editor of the Journal of Law and Public Policy. 

  • Listed among The Best Lawyers in America: Corporate Law (2021-2026), Corporate Governance Law (2022-2026), Mergers & Acquisitions Law (2026)
  • Listed among Business North Carolina Magazine Legal Elite: Business (2022)
  • Listed among North Carolina Super Lawyers “Rising Stars” Securities and Corporate Finance (2010, 2012, 2013), Mergers & Acquisitions (2025-2026)
  • North Carolina State Bar
  • North Carolina Bar Association
  • New York State Bar
  • Board of Directors, American Red Cross—Triangle Area Chapter; Philanthropy Committee Chairman (2017-2021)
  • Member, North Carolina Children’s Hospital Board of Visitors (2010-2016)
  • Represented global asset management firm in sales of royalty interests in respect of sales of certain pharmaceutical products to healthcare investment firm
  • Represented venture capital fund in its acquisition of innovative laboratory product and component development company
  • Represented Apiture, a provider of digital banking solutions to U.S. financial institutions, in its sale to Computer Services, Inc., a leading provider of end-to-end financial software and technology
  • Represented leading regional office and professional furniture distributor in its acquisition by family office
  • Represented leading technology advisory firm in its acquisition by private equity firm
  • Represented medical device company in the sale of its newborn screening laboratory solution to a biotechnology company specializing in genetic testing and diagnostics
  • Represented a leading provider of regulated material management services in a strategic growth investment from a leading healthcare-focused private equity firm
  • Represented venture-backed producer of tailored curriculums for clinical trials in sale to private equity sponsor
  • Represented developer of biological crop protection products in sale of biofungicide to biopesticide development company
  • Represented public clinical-stage biotechnology company in acquisition of privately held biotechnology development company